- Title: Subtitle
- WCN26-4069 EFFICACY AND SAFETY OF IPTACOPAN IN PARTICIPANTS WITH C3 GLOMERULOPATHY: C3G EXTENSION TRIAL INTERIM RESULTS FROM THE PHASE 3 APPEAR-C3G PARTICIPANTS
- Creators
- Carla M. Nester - University of IowaRichard J.H. Smith - University of IowaDavid Kavanagh - Newcastle UniversityMarina Vivarelli - Bambino Gesù Children's HospitalGiuseppe Remuzzi - Mario Negri Institute for Pharmacological ResearchMing-Hui Zhao - Peking UniversityEdwin K.S. Wong - Royal Victoria InfirmaryYaqin Wang - Tris Pharma (United States)Rubeen K. Israni - Tris Pharma (United States)Hari V. Kalluri - Novartis (Switzerland)Induja KrishnanJean Grisouard - Novartis (Switzerland)Andrew S. Bomback - Columbia University Irving Medical Center
- Resource Type
- Abstract
- Publication Details
- Kidney international reports, Vol.11(4 Supplement), 106215
- DOI
- 10.1016/j.ekir.2026.106215
- ISSN
- 2468-0249
- eISSN
- 2468-0249
- Publisher
- Elsevier
- Language
- English
- Date published
- 04/2026
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Molecular Physiology and Biophysics; Anatomy and Cell Biology; Nephrology, Dialysis and Transplantation; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Otolaryngology; Internal Medicine
- Record Identifier
- 9985149569502771
Abstract
WCN26-4069 EFFICACY AND SAFETY OF IPTACOPAN IN PARTICIPANTS WITH C3 GLOMERULOPATHY: C3G EXTENSION TRIAL INTERIM RESULTS FROM THE PHASE 3 APPEAR-C3G PARTICIPANTS
Kidney international reports, Vol.11(4 Supplement), 106215
04/2026
DOI: 10.1016/j.ekir.2026.106215
Details
Metrics
1 Record Views